Haematology Speakers 2008

Professor Charles Craddock
Charles Craddock trained in medicine at Oxford University and undertook specialist training in haematology at the Hammersmith Hospital, London. In order to pursue his interest in stem cell transplantation and leukaemia he undertook further research at Oxford and then in Seattle. He returned to the Hammersmith Hospital and in 1999 took up the post of Transplant Director at the University Hospital, Birmingham which is now one of the largest transplant units in the UK. His research interests include the development of novel drug and transplant therapies in myeloid malignancies.

Professor John Goldman 
John Goldman is Editor of Bone Marrow Transplantation, a former Editor of The Haematology Journal, and an associate Editor of the European Journal of Haematology.  As well as being the founding president of the British Society for Blood and Marrow Transplantation, Professor Goldman was also Chairman of the Department of Haematology at Imperial College in London, Director of the Leukaemia Research Fund Centre for Adult Leukaemia and Clinical Director of the Haematology Department at the Hammersmith Hospitals NHS Trust until 2004. Thereafter he took up a fixed term appointment as Fogarty Scholar at the National Institutes of Health in Bethesda, USA.  He combines a wide range of clinical, research and teaching responsibilities, and his professional interests include oncogenes and tumour suppressor genes in chronic myeloid leukaemia and the use of allogeneic stem cell transplantation and tyrosine kinase inhibitors for CML.

Professor Tony Green 
Tony Green is Head of the University of Cambridge Department of Haematology and Chairman of Addenbrooke's NHS Trust Department of Haematology.  He trained in medicine at the University of Cambridge and University College Hospital London completing his haematology training at the Royal Free Hospital and the University Hospital of Wales, Cardiff. He was elected to the Chair of Haemato-Oncology in Cambridge in 1999.  His research interests focus on two aspects of haematopoietic stem cell biology: the molecular pathogenesis of myeloid malignancies and the transcriptional regulation of haematopoietic stem.

Professor John Porter
John Porter is Professor of Haematology and Consultant Haematologist at University College London.  He trained in medicine at the University of Cambridge, and also completed an MD thesis in iron metabolism in 1999.  He is Chair of the British Society of Haematology symposia and Scientific Advisor to the UK Thalassaemia Society and the Thalassemia International Federation (TIF).

Dr Trevor Baglin
Trevor Baglin has been a Consultant Haematologist at Addenbrooke’s Hospital in Cambridge since 1990, where he has developed a multidisciplinary team for the treatment of bleeding and thrombotic disorders, promoting out-of-hospital care and self management. His main research interests are in the regulation of thrombin generation and the use of laboratory tests as a measure of thrombosis risk. He is currently Chair of the Haemostasis and Thrombosis Task Force for the British Society of Haematology, Co-Chair of the Scientific and Standardisation Committee scientific subcommittee on Control of Anticoagulation and a member of the Department of Health Implementation Working Group for the prevention of Venous Thromboembolism in hospitalised patients.